As the race to save the doctor's appointment heats up, clinical documentation company Abridge scored $150 million in Series C funds.
Why it matters: Coming on the heels of Abridge's Series B last fall, the hefty raise reflects strong investor interest in ambient tech companies looking to ease doctors' note-taking burden.
